WO2021167311A2 - Enzyme food composition for ameliorating obesity and skin wrinkles, comprising fast-fermented rhynchosia nulubilis paste and eel mucus - Google Patents
Enzyme food composition for ameliorating obesity and skin wrinkles, comprising fast-fermented rhynchosia nulubilis paste and eel mucus Download PDFInfo
- Publication number
- WO2021167311A2 WO2021167311A2 PCT/KR2021/001940 KR2021001940W WO2021167311A2 WO 2021167311 A2 WO2021167311 A2 WO 2021167311A2 KR 2021001940 W KR2021001940 W KR 2021001940W WO 2021167311 A2 WO2021167311 A2 WO 2021167311A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- food composition
- eel
- skin wrinkles
- enzyme food
- cheonggukjang
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 51
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 41
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 41
- 230000037303 wrinkles Effects 0.000 title claims abstract description 28
- 208000008589 Obesity Diseases 0.000 title claims abstract description 22
- 235000020824 obesity Nutrition 0.000 title claims abstract description 22
- 210000003097 mucus Anatomy 0.000 title abstract description 6
- 240000008301 Rhynchosia minima Species 0.000 title 1
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 18
- 239000003765 sweetening agent Substances 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims description 32
- 229920000715 Mucilage Polymers 0.000 claims description 25
- 239000000853 adhesive Substances 0.000 claims description 25
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 3
- 244000228451 Stevia rebaudiana Species 0.000 claims description 3
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims description 3
- 241000208140 Acer Species 0.000 claims description 2
- 240000004246 Agave americana Species 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 244000104275 Phoenix dactylifera Species 0.000 claims description 2
- 235000010659 Phoenix dactylifera Nutrition 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 230000003579 anti-obesity Effects 0.000 abstract description 10
- 235000019640 taste Nutrition 0.000 abstract description 7
- 230000004580 weight loss Effects 0.000 abstract description 6
- 241000913743 Rhynchosia Species 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 235000019645 odor Nutrition 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 35
- 210000003491 skin Anatomy 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 26
- 244000068988 Glycine max Species 0.000 description 16
- 235000010469 Glycine max Nutrition 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 230000006872 improvement Effects 0.000 description 11
- 230000009467 reduction Effects 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000544066 Stevia Species 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 230000035508 accumulation Effects 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 244000144730 Amygdalus persica Species 0.000 description 3
- 241000252073 Anguilliformes Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 235000016623 Fragaria vesca Nutrition 0.000 description 3
- 240000009088 Fragaria x ananassa Species 0.000 description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 3
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 3
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 238000007602 hot air drying Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241001635206 Conger conger Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241000251752 Myxine glutinosa Species 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 230000006372 lipid accumulation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- -1 that is Substances 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Definitions
- the present invention relates to an enzyme food composition for improving obesity and skin wrinkle, comprising cheonggukjang and eel mucilage.
- Enzyme food is one of the health supplement food items in Korea, and according to the Food Standards Code, edible microorganisms are cultivated in cereals (over 60.0%), or enzyme-containing parts are extracted from food, or the main raw material (50.0% or more) is prepared from it.
- Manufactured and processed food embryo enzyme food (food produced by culturing edible microorganisms in embryos (40.0% or more) of grains, or extracting enzyme-containing parts from food, or manufactured and processed using these as main raw materials (50.0% or more))
- Fruit/vegetable enzyme food food produced by culturing edible microorganisms on fruits/vegetables (60.0% or more), or extracting enzyme-containing parts from food, or manufactured/processed using it as the main raw material (50.0% or more)
- other plant enzymes Products containing edible microorganisms (above grains, grain embryos, or vegetable raw materials other than fruits and vegetables (60.0% or more)) ) and so on.
- Cheonggukjang is Korea's representative fermented food made from soybeans, and it is one of the traditional soybean pastes that have been commercialized until today along with soy sauce, soybean paste, and red pepper paste. It played an important role as a food supplying essential amino acids and fatty acids, which are easily deficient in our people, whose staple food is grains. Cheonggukjang is made by floating boiled soybeans using Bacillus subtilis, called Bacillus subtilis, which is attached to rice straw. It produces a large amount of mucilage, which is a mixture of protein-derived levan form fructan and polyglutamate. The fermented cheonggukjang is a high-quality soybean fermented food with higher protein and fat content than doenjang or red pepper paste in terms of digestion as well as nutrition.
- cheonggukjang is fermented at high temperature without using salt, so it can be completed in a short time of about 2 to 3 days, so it is highly efficient in terms of nutrition and economy, and has antioxidant, thrombolytic, and antibiotic properties. It is also used as a functional processed food such as powder, pill, capsule, etc. as it is said to be effective in secretion, blood sugar and serum lipid reduction, cancer cell suppression, DNA damage recovery, obesity, cancer, blood clots, diabetes, and high blood pressure.
- Mucin is a mucous substance secreted from the mucous membrane of an organism and is present in the pituitary gland, gastric mucosa, cartilage, saliva, blood, runny nose, etc.
- the chemical body of mucin is a type of glycoprotein, but contains several glycoproteins depending on the origin or type of mucin. Mucin is difficult to dissolve in water and neutral salt solution, and it is insoluble and precipitated in acid, but has the characteristic of becoming a viscous liquid in alkali. Mucin in the digestive system acts as a protective agent for the organs and a lubricant for digestive movement.
- Mucin in the gastric mucosa plays a role in preventing damage caused by pepsin and gastric acid, so it is used to treat hyperacidity and gastric ulcer
- mucin in the intestine is an amino acid It plays a role in helping the absorption of fat or fat, and mucin secreted from the large intestine acts as a lubricant in the intestine, allowing foreign substances attached to the intestinal lumen to fall off smoothly.
- mucin contains chondroitin, a natural complex material such as collagen, elastin, and protein, which prevents moisture loss from the harsh external environment, prevents drying of the skin, and plays a role in rapidly regenerating damaged skin. Therefore, the mucin component is spotlighted as a new material for skin moisturizing, antioxidant, wrinkle improvement, atopy improvement, and the like.
- the eel discharges secretions from the skin to protect the skin, and it is known that the mucin content is high in these skin secretions. In addition, it is distributed in Korea, China, and Japan and is also farmed, so mucin is extracted using the skin secretions of eels and used as cosmetics.
- the development of cosmetic materials and cosmetics using mucin's water-retaining properties and skin regenerative ability is being actively carried out. In particular, cosmetics using mucin extracted from snails and hemp, that is, cosmetics using mucin, have been released, but the mucin properties of discarded eels. There are very few examples of substances used as food.
- Korean Patent No. 10-1460669 discloses fish having a mucinous epidermis (sea eel, eel, hagfish, A cosmetic composition for skin wrinkle improvement, antioxidant, whitening, moisturizing, atopy improvement, skin barrier improvement, and anti-inflammatory using A manufacturing method has been disclosed, and Korean Patent Application Laid-Open No. 10-2009-0105202 discloses cheonggukjang pills for body fat control containing cheonggukjang and oriental medicine ingredients (including rat eye beans), and Korean Patent Publication No.
- 10-2019-0027236 discloses anti-obesity effect An excellent fermented seomoktae extract and a method for producing the same have been disclosed. However, as in the present invention, there has been no previous report confirming that a mixture of cheonggukjang powder and eel mucilage powder in a specific ratio is excellent for improving obesity and skin wrinkles as in the present invention.
- the present inventors completed the present invention by confirming that, in the process of researching an enzyme food composition, a composition containing cheonggukjang and eel mucilage has excellent anti-obesity effect while preventing skin wrinkles that may appear during weight loss.
- the present invention relates to an enzyme food composition for improving obesity and skin wrinkle, comprising cheonggukjang, eel mucilage and sweetener.
- Any commercially available cheonggukjang can be used, and even if it is manufactured, any cheonggukjang prepared by a conventional cheonggukjang can be used.
- a dry (dried by a conventional method such as hot air drying, freeze-drying, etc.) powder that can be easily ingested rather than using the raw material, and more preferably freeze-dried so that there is little loss of nutrients
- a dry (dried by a conventional method such as hot air drying, freeze-drying, etc.) powder that can be easily ingested rather than using the raw material, and more preferably freeze-dried so that there is little loss of nutrients
- a dry soybean fermented soybean paste powder use dried soybean fermented soybean paste powder.
- the eel mucilage is preferably obtained by applying stimulation or stress (electricity, etc.) to live eel to collect the mucus secreted from the eel skin, and more preferably remove foreign substances from the collected mucus and then dry (hot air drying, freeze drying, etc. Drying by phosphorus method) powder is used, and most preferably, freeze-dried powder is used.
- stimulation or stress electricality, etc.
- the sweetener is a low-calorie sweetener that replaces sugar and gives sweetness.
- Stevia, honey, aspartame, erythritol, xylitol, date palm, maple syrup, agave syrup, sucanat, etc. are used, or powder obtained by freeze-drying fruit (strawberry powder, peach) Powder, etc.) is not particularly limited as long as it is a low-calorie sweetener for the prevention or improvement of obesity resulting from excessive intake, such as the use of powder.
- the enzyme food composition includes the form of tablets, capsules, pills and liquids, etc., and the food composition itself is prepared in the form of tea, juice, and drink to be consumed, or granulated, encapsulated and powdered. .
- the present invention relates to an enzyme food composition for improving obesity and skin wrinkle, comprising cheonggukjang, eel mucilage and sweetener.
- the mixture has excellent anti-obesity effect while preventing skin wrinkles that may appear during weight loss compared to a single composition, and is easy to ingest because unpleasant taste and flavor are removed when ingested. It can be used as an improvement enzyme food composition.
- the cheonggukjang and eel mucilage contained in the enzyme food composition of the present invention were prepared and used in freeze-dried powder as follows, and a commercial product or natural fruit freeze-dried powder was used as the sweetener.
- the eel mucilage stimulated the secretion of mucus on the surface of the eel by stunning the eels with an electric shock, and then the mucilage from the live eel epidermis was retaken. After removing the foreign substances in the mucilage, freeze-drying was performed to obtain a freeze-dried eel mucin powder containing a mucin component.
- the freeze-dried soybean soybean eel powder and freeze-dried eel mucilage powder and sweetener obtained from the above process were mixed under the conditions shown in Table 1 below to obtain an enzyme food composition comprising the present invention cheonggukjang, eel mucilage and sweetener.
- Example 1 7 2 1 (Stevia)
- Example 2 8 One 1 (Stevia)
- Example 3 7.9 2 0.1 (stevia)
- Example 4 6.5 2 1.5
- Example 5 7 2 1 (strawberry powder)
- Example 6 7 2 1 (peach powder)
- Example 7 7 2 0.5 (stevia), 0.25 (strawberry powder), 0.25 (peach powder)
- An enzyme food composition for comparison was prepared using the freeze-dried powder of chungkukjang, eel mucilage, and sweetener of Example 1, but referring to the mixing ratio in Table 2 below.
- the effect of improving obesity was confirmed from the fat accumulation inhibitory effect of the enzyme food composition of the present invention in 3T3-L1 cells, which are adipocytes.
- DMEM medium Dulbecco's modified Eagle's medium
- 3T3-L1 adipocytes were aliquoted on the plate and the cells were grown to 100% (confluent stage), 2 days later, 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine (3-isobutyl-1-methylxanthine, IBMX), 1 ⁇ g/ml insulin, and DMEM medium containing 1 ⁇ M dexamethasone were used to induce differentiation. After 3 days, it was replaced with DMEM medium containing 10% FBS and 10 ⁇ g/ml insulin, treated for 2 days, and then replaced with DMEM medium containing 10% FBS, and further treated for 2 more days.
- the enzyme food composition of the present invention was dissolved in DMSO and treated with a differentiation induction medium at 200 ⁇ g/ml from the time of differentiation induction.
- the cells were washed with PBS and fixed with 10% formaldehyde for 1 hour or more, and then the cells were washed 3 to 4 times with 60% isopropanol.
- Oil red O solution was added to each well, stained for 10 minutes, and washed with distilled water. Thereafter, fat was extracted by dissolving Oil red O dye in 100% isopropanol, and then the fat glomerular accumulation rate was evaluated at absorbance at 520 nm.
- the enzyme food composition (200 ⁇ g / ml treatment) of the embodiment of the present invention showed a synergistic effect on the inhibition of lipid accumulation.
- the present inventors prepared an enzyme food composition at various mixing ratios and confirmed the fat globules accumulation rate, and as a result, it was confirmed that the composition prepared at a mixing ratio different from the above example had a low synergistic effect by mixing.
- Examples 1 to 7, which is a cheonggukjang powder of rat eyes have superior anti-obesity effect compared to Comparative Example 8, which is a cheonggukjang powder using ordinary soybeans.
- the subcultured HaCaT cells were dispensed on the plate, and the enzyme food composition of Examples or Comparative Examples of the present invention was dissolved in DMSO, treated with 200 ⁇ g/ml, and cultured for 24 hours. Thereafter, the cells were irradiated with UV-B (30 mJ/cm 2 ) and cultured for 24 hours, and then the mRNA expression level of MMP-1 was confirmed from the cells, and the results are shown in Table 4.
- the enzyme food composition has excellent anti-obesity effect and skin wrinkle improvement effect, so it can be seen that it is a composition that can be easily used as an enzyme food composition for improving obesity and skin wrinkle with excellent anti-obesity effect while preventing skin wrinkles that may appear during weight loss. there was.
- the enzyme food composition of the present invention is easy to consume because unpleasant taste and flavor are removed when ingested. Therefore, as in the present invention, a mixture of cheonggukjang powder and eel mucilage powder in a specific ratio as in the present invention prevents skin wrinkles that may appear during weight loss, has an excellent anti-obesity effect, and is easy to consume because unpleasant taste and flavor are removed when ingested It was found that the composition can be easily used as an enzyme food composition for improving obesity and skin wrinkles by utilizing the discarded eel mucilage.
Abstract
The present invention relates to an enzyme food composition for ameliorating obesity and skin wrinkles, the composition comprising fast-fermented Rhynchosia nulubilis paste, eel mucus, and a sweetener. The mixture prevents skin wrinkles which can occur during weight loss and has an excellent anti-obesity effect as compared to the composition alone, is easy to ingest due to the elimination of unpleasant tastes and odors when ingested, and can utilize discarded eel mucus, and thus can be used as an eco-friendly enzyme food composition for ameliorating obesity and skin wrinkles.
Description
본 발명은 쥐눈이콩 청국장 및 장어 점액질을 포함하는 비만 및 피부 주름 개선용 효소 식품 조성물에 관한 것이다.The present invention relates to an enzyme food composition for improving obesity and skin wrinkle, comprising cheonggukjang and eel mucilage.
효소 식품은 우리나라의 건강보조식품 품목 중 하나로, 식품공전에는 곡류효소식품(곡류(60.0% 이상)에 식용미생물을 배양시키거나 식품에서 효소함유부분을 추출한 것 또는 이를 주원료(50.0% 이상)로 하여 제조·가공한 것), 배아효소식품(곡물의 배아(40.0% 이상)에 식용미생물을 배양시키거나 식품에서 효소함유부분을 추출한 것 또는 이를 주원료(50.0% 이상)로 하여 제조·가공한 것), 과·채류효소식품(과·채류(60.0% 이상)에 식용미생물을 배양시키거나 식품에서 효소함유부분을 추출한 것 또는 이를 주원료(50.0% 이상)로 하여 제조·가공한 것), 기타 식물효소함유제품(곡류, 곡물배아 또는 과·채류 이외의 식물성 원료(60.0% 이상)에 식용미생물을 배양시키거나 식품에서 효소함유부분을 추출한 것 또는 이를 주원료(50.0% 이상)로 하여 제조·가공한 것) 등의 유형이 있다. 즉, 식용미생물을 배양한 것 또는 식품에서 효소함유부분을 추출한 것 또는 이를 주원료로 하여 섭취가 용이하도록 페이스트상, 분말, 과립, 정제, 캡슐 등으로 가공한 것을 말하며, 신진대사 기능에 관여하고 건강증진 및 유지에 도움을 주는 것으로 알려져 많은 효소 식품들이 개발되어 왔다.Enzyme food is one of the health supplement food items in Korea, and according to the Food Standards Code, edible microorganisms are cultivated in cereals (over 60.0%), or enzyme-containing parts are extracted from food, or the main raw material (50.0% or more) is prepared from it. Manufactured and processed food), embryo enzyme food (food produced by culturing edible microorganisms in embryos (40.0% or more) of grains, or extracting enzyme-containing parts from food, or manufactured and processed using these as main raw materials (50.0% or more)) , Fruit/vegetable enzyme food (food produced by culturing edible microorganisms on fruits/vegetables (60.0% or more), or extracting enzyme-containing parts from food, or manufactured/processed using it as the main raw material (50.0% or more)), other plant enzymes Products containing edible microorganisms (above grains, grain embryos, or vegetable raw materials other than fruits and vegetables (60.0% or more)) ) and so on. That is, it refers to a product obtained by culturing edible microorganisms or extracting an enzyme-containing part from food or processing it into a paste, powder, granule, tablet, capsule, etc. Many enzyme foods have been developed that are known to help promote and maintain.
청국장은 콩을 원료로 한 우리나라의 대표적인 발효식품으로서, 간장, 된장, 고추장 등과 함께 오늘날까지 상용되어 온 전통 장류 중의 하나이다. 곡류를 주식으로 하는 우리민족에게 결핍되기 쉬운 필수아미노산 및 지방산을 공급시켜 주는 식품으로서 중요한 역할을 담당하였다. 청국장은 삶은 콩을 볏짚에 붙어있는 고초균이라 부르는 바실러스 서브틸리스(Bacillus subtilis)를 이용하여 띄워 만든 것으로, 발효과정 중에 고초균이 생산하는 효소에 의해서 그 특유의 맛과 냄새를 내며 원료콩의 당질과 단백질에서 유래된 레반형프룩탄(levan form fructan)과 폴리글루타메이트(polyglutamate)의 혼합물질인 점질물을 다량 생성한다. 발효 제조된 청국장은 소화 작용뿐만 아니라 영양면에서도 된장이나 고추장보다 단백질과 지방 함량이 높은 양질의 콩 발효식품이다. Cheonggukjang is Korea's representative fermented food made from soybeans, and it is one of the traditional soybean pastes that have been commercialized until today along with soy sauce, soybean paste, and red pepper paste. It played an important role as a food supplying essential amino acids and fatty acids, which are easily deficient in our people, whose staple food is grains. Cheonggukjang is made by floating boiled soybeans using Bacillus subtilis, called Bacillus subtilis, which is attached to rice straw. It produces a large amount of mucilage, which is a mixture of protein-derived levan form fructan and polyglutamate. The fermented cheonggukjang is a high-quality soybean fermented food with higher protein and fat content than doenjang or red pepper paste in terms of digestion as well as nutrition.
청국장은 다른 대두 발효식품과는 달리 소금을 사용하지 않고 고온에서 발효시키기 때문에 2~3일 정도의 짧은 시간 내에 완성할 수 있으므로 영양 면에서나 경제적인 면에서 효율성이 높고, 항산화, 혈전 용해, 항생물질 분비, 혈당 및 혈청 지질 감소, 암세포 억제, DNA 손상 회복 작용, 비만, 암, 혈전, 당뇨, 고혈압 등에 효능이 있다고 하여 가루, 환, 캡슐 등 기능성 가공식품으로도 활용되고 있다.Unlike other fermented soybean foods, cheonggukjang is fermented at high temperature without using salt, so it can be completed in a short time of about 2 to 3 days, so it is highly efficient in terms of nutrition and economy, and has antioxidant, thrombolytic, and antibiotic properties. It is also used as a functional processed food such as powder, pill, capsule, etc. as it is said to be effective in secretion, blood sugar and serum lipid reduction, cancer cell suppression, DNA damage recovery, obesity, cancer, blood clots, diabetes, and high blood pressure.
뮤신(mucin)은 생물체의 점막에서 분비되는 점액성 물질로 동물의 뇌하수체, 위점막, 연골, 침, 혈액, 콧물 등에 존재하며, 달팽이, 장어, 미꾸라지 등의 피부에 다량 함유되어 있다. 뮤신의 화학적 본체는 당단백질의 일종이나, 점액의 기원이나 종류에 따라 여러 가지 당단백질을 함유한다. 뮤신은 물과 중성염용액에는 녹기 어렵고 산성에서는 녹지 않고 침전되나, 알칼리성에서는 점성질의 액이 되는 특성이 있다. 소화 기관에서의 뮤신은 기관의 보호 및 소화 운동의 윤활제 역할을 하며, 위점막에서의 뮤신은 펩신과 위산에 의한 손상을 방지하는 역할을 해서 위산과다와 위궤양 치료에 사용되고, 장에서의 뮤신은 아미노산이나 지방의 흡수를 돕는 역할을 하며 대장에서 분비되는 뮤신은 장내에서 윤활제 기능을 하여 장 내강에 붙어 있는 이물질이 매끄럽게 잘 떨어지게 한다. 또한, 뮤신은 콜라겐, 엘라스틴, 단백질 등 천연 복합물질인 콘드로이친을 함유하고 있어 외부의 거친 환경으로부터 수분손실을 막아 피부의 건조를 막아주며, 상처가 난 피부를 빠르게 재생시켜 주는 역할을 한다. 따라서, 뮤신 성분은 피부의 보습, 항산화, 주름개선, 아토피개선 등을 위한 새로운 물질로 각광받고 있다.Mucin is a mucous substance secreted from the mucous membrane of an organism and is present in the pituitary gland, gastric mucosa, cartilage, saliva, blood, runny nose, etc. The chemical body of mucin is a type of glycoprotein, but contains several glycoproteins depending on the origin or type of mucin. Mucin is difficult to dissolve in water and neutral salt solution, and it is insoluble and precipitated in acid, but has the characteristic of becoming a viscous liquid in alkali. Mucin in the digestive system acts as a protective agent for the organs and a lubricant for digestive movement. Mucin in the gastric mucosa plays a role in preventing damage caused by pepsin and gastric acid, so it is used to treat hyperacidity and gastric ulcer, and mucin in the intestine is an amino acid It plays a role in helping the absorption of fat or fat, and mucin secreted from the large intestine acts as a lubricant in the intestine, allowing foreign substances attached to the intestinal lumen to fall off smoothly. In addition, mucin contains chondroitin, a natural complex material such as collagen, elastin, and protein, which prevents moisture loss from the harsh external environment, prevents drying of the skin, and plays a role in rapidly regenerating damaged skin. Therefore, the mucin component is spotlighted as a new material for skin moisturizing, antioxidant, wrinkle improvement, atopy improvement, and the like.
장어는 피부 보호를 위하여 피부에서 분비물을 배출하는데, 이러한 피부분비물에는 뮤신 함량이 높은 것으로 알려져 있다. 또한 우리나라, 중국, 일본 등지에 분포하며 양식도 하고 있어, 장어의 피부 분비물을 활용하여 뮤신을 추출하고 이를 화장품으로도 활용하고 있다. 이러한 뮤신의 수분보유성 및 피부의 재생능을 이용한 화장제재 및 화장품의 개발이 활발히 이루어지고 있는데, 특히 달팽이와 마로부터 추출된 점액성 물질 즉 뮤신을 이용한 화장품은 출시되었으나, 폐기되는 장어의 점액성 물질을 활용하여 식품으로 활용된 예는 거의 없다.The eel discharges secretions from the skin to protect the skin, and it is known that the mucin content is high in these skin secretions. In addition, it is distributed in Korea, China, and Japan and is also farmed, so mucin is extracted using the skin secretions of eels and used as cosmetics. The development of cosmetic materials and cosmetics using mucin's water-retaining properties and skin regenerative ability is being actively carried out. In particular, cosmetics using mucin extracted from snails and hemp, that is, cosmetics using mucin, have been released, but the mucin properties of discarded eels. There are very few examples of substances used as food.
한편, 쥐눈이콩 청국장 및 장어 점액질을 포함하는 비만 또는 피부 주름 개선용 효소 식품 조성물과 관련된 종래선행문헌으로서, 한국등록특허 제10-1460669호에는 점액성 표피를 갖는 어류(바다장어, 뱀장어, 먹장어, 메기)를 이용한 피부 주름 개선, 항산화, 미백, 보습, 아토피개선, 피부장벽개선, 항염증용 화장료 조성물이 개시되었고, 한국등록특허 제10-2002337호에는 검은콩(서목태, 서리태, 흑태) 청국장의 제조방법이 개시되었으며, 한국공개특허 제10-2009-0105202호에는 청국장과 한약소재(쥐눈이콩 포함)를 포함하는 체지방 조절용 청국장 환이 개시되었고, 한국공개특허 제10-2019-0027236호에는 항비만 효과가 우수한 발효서목태 엑기스 및 이의 제조방법이 개시된 바 있다. 그러나 본 발명과 같이 쥐눈이콩 청국장 분말 및 장어 점액질 분말을 특정 비율로 혼합한 혼합물이 비만 및 피부 주름 개선용 효과가 우수함을 확인한 이전 보고는 아직 없다.On the other hand, as a prior literature related to an enzyme food composition for improving obesity or skin wrinkles containing cheonggukjang and eel mucilage, Korea Patent No. 10-1460669 discloses fish having a mucinous epidermis (sea eel, eel, hagfish, A cosmetic composition for skin wrinkle improvement, antioxidant, whitening, moisturizing, atopy improvement, skin barrier improvement, and anti-inflammatory using A manufacturing method has been disclosed, and Korean Patent Application Laid-Open No. 10-2009-0105202 discloses cheonggukjang pills for body fat control containing cheonggukjang and oriental medicine ingredients (including rat eye beans), and Korean Patent Publication No. 10-2019-0027236 discloses anti-obesity effect An excellent fermented seomoktae extract and a method for producing the same have been disclosed. However, as in the present invention, there has been no previous report confirming that a mixture of cheonggukjang powder and eel mucilage powder in a specific ratio is excellent for improving obesity and skin wrinkles as in the present invention.
이에 본 발명자들은 효소 식품 조성물을 연구하는 과정에서, 쥐눈이콩 청국장 및 장어 점액질을 포함하는 조성물이 체중 감량시 나타날 수 있는 피부 주름을 방지하면서도 항비만 효과는 우수함을 확인함으로써 본 발명을 완성하였다.Accordingly, the present inventors completed the present invention by confirming that, in the process of researching an enzyme food composition, a composition containing cheonggukjang and eel mucilage has excellent anti-obesity effect while preventing skin wrinkles that may appear during weight loss.
본 발명의 목적은 체중 감량시 나타날 수 있는 피부 주름을 방지하면서도 항비만 효과는 우수한 쥐눈이콩 청국장 및 장어 점액질을 포함하는 비만 및 피부 주름 개선용 효소 식품 조성물을 제공하는 데 있다.It is an object of the present invention to provide an enzyme food composition for improving obesity and skin wrinkle, comprising cheonggukjang and eel mucilage, which has excellent anti-obesity effect while preventing skin wrinkles that may appear during weight loss.
본 발명은 쥐눈이콩 청국장, 장어 점액질 및 감미료를 포함하는 비만 및 피부 주름 개선용 효소 식품 조성물에 관한 것이다.The present invention relates to an enzyme food composition for improving obesity and skin wrinkle, comprising cheonggukjang, eel mucilage and sweetener.
상기 쥐눈이콩 청국장은 시판되는 제품이라면 모두 사용가능하며, 제조하는 경우에도 통상의 청국장 제조방법으로 제조한 쥐눈이콩 청국장이라면 모두 사용가능하다. Any commercially available cheonggukjang can be used, and even if it is manufactured, any cheonggukjang prepared by a conventional cheonggukjang can be used.
또한, 상기 쥐눈이콩 청국장은 원물을 사용하는 것 보다는 용이 섭취가 가능한 건조(열풍건조, 동결건조 등 통상적인 방법으로 건조) 분말을 사용하는 것이 바람직하며, 보다 바람직하게는 영양소 손실이 거의 없도록 동결건조방법으로 건조한 쥐눈이콩 청국장 분말을 사용한다. In addition, it is preferable to use a dry (dried by a conventional method such as hot air drying, freeze-drying, etc.) powder that can be easily ingested rather than using the raw material, and more preferably freeze-dried so that there is little loss of nutrients As a method, use dried soybean fermented soybean paste powder.
상기 장어 점액질은 바람직하게 살아있는 장어에 자극이나 스트레스(전기 등)를 가하여 장어 피부로부터 분비된 점액질을 채취하며, 보다 바람직하게는 상기 채취된 점액질의 이물질을 제거한 다음 건조(열풍건조, 동결건조 등 통상적인 방법으로 건조) 분말을 사용하며, 가장 바람직하게는 동결건조한 분말을 사용한다.The eel mucilage is preferably obtained by applying stimulation or stress (electricity, etc.) to live eel to collect the mucus secreted from the eel skin, and more preferably remove foreign substances from the collected mucus and then dry (hot air drying, freeze drying, etc. Drying by phosphorus method) powder is used, and most preferably, freeze-dried powder is used.
상기 감미료는 설탕을 대체하여 단맛을 주는 저칼로리 감미료로서 스테비아, 꿀, 아스파탐, 에리스리톨, 자일리톨, 대추야자, 메이플시럽, 아가베시럽, 수카나트 등을 사용하거나, 과일을 동결건조한 분말(딸기 분말, 복숭아 분말 등)을 사용하는 등 과잉 섭취에서 생기는 비만의 예방 또는 개선을 위한 저칼로리 감미료라면 특별히 제한되지 않는다. The sweetener is a low-calorie sweetener that replaces sugar and gives sweetness. Stevia, honey, aspartame, erythritol, xylitol, date palm, maple syrup, agave syrup, sucanat, etc. are used, or powder obtained by freeze-drying fruit (strawberry powder, peach) Powder, etc.) is not particularly limited as long as it is a low-calorie sweetener for the prevention or improvement of obesity resulting from excessive intake, such as the use of powder.
상기 쥐눈이콩 청국장, 장어 점액질 및 감미료는 6.5~8:1~2:0.1~1.5의 혼합비로 혼합하여 사용하는 것이 비만 및 피부 주름 개선에 효과적이다. It is effective in improving obesity and skin wrinkles by mixing and using the cheonggukjang, eel mucilage and sweetener in a mixing ratio of 6.5-8:1-2:0.1-1.5.
그러나 상기 조건을 벗어나서 쥐눈이콩 청국장, 장어 점액질 및 감미료를 모두 포함하지 않고 쥐눈이콩 청국장, 장어 점액질 및 감미료를 임의 선택하여 사용하는 경우에는 비만 및 피부 주름의 동시 개선 효과가 없거나 효과가 낮아 바람직하지 않고, 상기 쥐눈이콩 청국장, 장어 점액질 및 감미료를 모두 포함하더라도 상기 혼합비를 벗어나는 경우에는 비만 및 피부 주름 개선 효과가 낮거나 효과 상승폭이 크지 않아 경제적이지 않으므로 바람직하지 않다. However, outside of the above conditions, when cheonggukjang, eel mucilage and sweetener are not included and cheonggukjang, eel mucilage and sweetener are randomly selected and used, there is no effect of simultaneously improving obesity and skin wrinkles, or the effect is low, which is undesirable. , even if it includes all of the cheonggukjang, eel mucilage and sweetener, it is not preferable because it is not economical because the effect of improving obesity and skin wrinkles is low or the effect increase is not large when the mixing ratio is out of the above mixing ratio.
상기 효소 식품 조성물은 정제, 캡슐제, 환제 및 액제 등의 형태를 포함하며, 식품 조성물 자체를 차, 쥬스 및 드링크의 형태로 제조하여 음용하도록 하거나, 과립화, 캡슐화 및 분말화하여 섭취할 수도 있다.The enzyme food composition includes the form of tablets, capsules, pills and liquids, etc., and the food composition itself is prepared in the form of tea, juice, and drink to be consumed, or granulated, encapsulated and powdered. .
본 발명은 쥐눈이콩 청국장, 장어 점액질 및 감미료를 포함하는 비만 및 피부 주름 개선용 효소 식품 조성물에 관한 것이다. 상기 혼합물은 단독 조성물에 비해 체중 감량시 나타날 수 있는 피부 주름을 방지하면서도 항비만 효과는 우수하고 섭취시 불쾌한 맛과 향이 제거되어 섭취가 용이하며 폐기되는 장어 점액질을 활용할 수 있어 친환경적인 비만 및 피부 주름 개선용 효소 식품 조성물로 사용 가능하다.The present invention relates to an enzyme food composition for improving obesity and skin wrinkle, comprising cheonggukjang, eel mucilage and sweetener. The mixture has excellent anti-obesity effect while preventing skin wrinkles that may appear during weight loss compared to a single composition, and is easy to ingest because unpleasant taste and flavor are removed when ingested. It can be used as an improvement enzyme food composition.
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지고, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, it is provided so that this disclosure will be thorough and complete, and will fully convey the spirit of the invention to those skilled in the art.
<실시예 1. 쥐눈이콩 청국장, 장어 점액질 및 감미료를 포함하는 효소 식품 조성물 제조><Example 1. Preparation of Enzyme Food Composition Containing Soybean Soybean Soybean Paste, Eel Slime and Sweetener>
본 발명 효소 식품 조성물에 포함되는 쥐눈이콩 청국장 및 장어 점액질은 하기와 같이 동결건조 분말로 제조하여 사용하였고, 감미료는 시판 제품 또는 천연 과일 동결건조 분말을 사용하였다.The cheonggukjang and eel mucilage contained in the enzyme food composition of the present invention were prepared and used in freeze-dried powder as follows, and a commercial product or natural fruit freeze-dried powder was used as the sweetener.
먼저 쥐눈이콩 청국장은 쥐눈이콩을 세척하여 12시간 이상 물에 불린다음 뜨거운 물에 2~3시간 약불로 삶아서 쥐눈이콩이 으깨질정도가 되면 고초균(바실러스 서브틸리스)을 접종하여 35~40℃에서 48시간 동안 발효시킨다. 발효된 쥐눈이콩 청국장을 동결건조하여 쥐눈이콩 청국장 동결건조 분말을 얻었다. First, wash the soybean sprouts and soak them in water for more than 12 hours, then boil them in hot water for 2-3 hours on low heat. Ferment for 48 hours. By freeze-drying the fermented soybean chungkukjang, a freeze-dried powder of cheonggukjang was obtained.
다음으로 장어 점액질은 장어를 전기충격으로 집단 기절시킴으로써 장어의 표면에 있는 점액질 분비를 촉진시킨 후, 살아있는 장어표피부분의 점액질을 재취하였다. 상기 점액질의 이물질을 제거한 다음 동결건조하여 뮤신 성분이 함유된 장어 점액질 동결건조 분말을 얻었다.Next, the eel mucilage stimulated the secretion of mucus on the surface of the eel by stunning the eels with an electric shock, and then the mucilage from the live eel epidermis was retaken. After removing the foreign substances in the mucilage, freeze-drying was performed to obtain a freeze-dried eel mucin powder containing a mucin component.
상기 과정으로부터 얻은 쥐눈이콩 청국장 동결건조 분말 및 장어 점액질 동결건조 분말과 감미료를 하기 표 1의 조건으로 혼합하여, 본 발명 쥐눈이콩 청국장, 장어 점액질 및 감미료를 포함하는 효소 식품 조성물을 얻었다.The freeze-dried soybean soybean eel powder and freeze-dried eel mucilage powder and sweetener obtained from the above process were mixed under the conditions shown in Table 1 below to obtain an enzyme food composition comprising the present invention cheonggukjang, eel mucilage and sweetener.
조건condition | 혼합비mixing ratio | ||
쥐눈이콩 청국장 동결건조 분말Freeze-dried Soybean Soybean Soybean Powder |
장어 점액질 동결건조 분말eel slime lyophilized powder |
감미료sweetener | |
실시예 1Example 1 | 77 | 22 | 1(스테비아)1 (Stevia) |
실시예 2Example 2 | 88 | 1One | 1(스테비아)1 (Stevia) |
실시예 3Example 3 | 7.97.9 | 22 | 0.1(스테비아)0.1 (stevia) |
실시예 4Example 4 | 6.56.5 | 22 | 1.5(스테비아)1.5 (Stevia) |
실시예 5Example 5 | 77 | 22 | 1(딸기분말)1 (strawberry powder) |
실시예 6Example 6 | 77 | 22 | 1(복숭아분말)1 (peach powder) |
실시예 7Example 7 | 77 | 22 |
0.5(스테비아), 0.25(딸기분말), 0.25(복숭아분말)0.5 (stevia), 0.25 (strawberry powder), 0.25 (peach powder) |
<비교예 1. 비교대상 효소 식품 조성물 제조><Comparative Example 1. Preparation of comparative enzyme food composition>
상기 실시예 1의 쥐눈이콩 청국장 동결건조 분말 및 장어 점액질 동결건조 분말과 감미료를 이용하되 하기 표 2의 혼합비를 참고하여 비교대상 효소 식품 조성물을 제조하였다.An enzyme food composition for comparison was prepared using the freeze-dried powder of chungkukjang, eel mucilage, and sweetener of Example 1, but referring to the mixing ratio in Table 2 below.
조건condition | 혼합비mixing ratio | ||
쥐눈이콩 청국장 동결건조 분말Freeze-dried Soybean Soybean Soybean Powder |
장어 점액질 동결건조 분말eel slime lyophilized powder |
감미료sweetener | |
비교예 1Comparative Example 1 | 1010 | 00 | 00 |
비교예 2Comparative Example 2 | 00 | 1010 | 00 |
비교예 3Comparative Example 3 | 55 | 55 | 00 |
비교예 4Comparative Example 4 | 66 | 44 | 00 |
비교예 5Comparative Example 5 | 99 | 1One | 00 |
비교예 6Comparative Example 6 | 44 | 66 | 00 |
비교예 7Comparative Example 7 | 33 | 77 | 00 |
비교예 8Comparative Example 8 |
7 (일반 메주콩 청국장 분말)7 (General Soybean Soybean Soybean Paste Powder) |
22 | 1(스테비아)1 (Stevia) |
<실험예 1. 비만 개선 효과 확인> <Experimental Example 1. Confirmation of obesity improvement effect>
지방세포인 3T3-L1 세포에서 본 발명 효소 식품 조성물의 처리에 따른 지방 축적 억제 효과로부터 비만 개선 효과를 확인하였다.The effect of improving obesity was confirmed from the fat accumulation inhibitory effect of the enzyme food composition of the present invention in 3T3-L1 cells, which are adipocytes.
3T3-L1 세포의 배양과 유지를 위해 DMEM 배지(Dulbecco's modified Eagle's medium)에 10% FBS와 1% 페니실린/스트렙토마이신(1% penicillin/streptomycin)을 첨가하여 37℃ 및 5% CO2 조건에서 계대 배양하였다.For culture and maintenance of 3T3-L1 cells, 10% FBS and 1% penicillin/streptomycin (1% penicillin/streptomycin) were added to DMEM medium (Dulbecco's modified Eagle's medium) and subcultured at 37°C and 5% CO 2 conditions. did.
3T3-L1 지방세포를 플레이트에 분주하고 세포가 100%로 성장(confluent stage)하면, 2일 후 10% FBS, 0.5mM 3-이소부틸-1-메틸크산틴(3-isobutyl-1-methylxanthine, IBMX), 1㎍/㎖ 인슐린, 1μM 덱사메타손이 포함된 DMEM 배지를 사용하여 분화를 유도하였다. 3일 후 10% FBS, 10㎍/㎖ 인슐린이 포함된 DMEM 배지로 교체하고 2일 동안 처리한 다음, 10% FBS가 포함된 DMEM 배지로 교체하여 2일 더 추가 처리하였다. 본 발명 효소 식품 조성물은 DMSO에 녹여 분화 유도 시점부터 분화유도 배지와 함께 200㎍/㎖로 처리하였다.3T3-L1 adipocytes were aliquoted on the plate and the cells were grown to 100% (confluent stage), 2 days later, 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine (3-isobutyl-1-methylxanthine, IBMX), 1 μg/ml insulin, and DMEM medium containing 1 μM dexamethasone were used to induce differentiation. After 3 days, it was replaced with DMEM medium containing 10% FBS and 10 μg/ml insulin, treated for 2 days, and then replaced with DMEM medium containing 10% FBS, and further treated for 2 more days. The enzyme food composition of the present invention was dissolved in DMSO and treated with a differentiation induction medium at 200 μg/ml from the time of differentiation induction.
이후 세포를 PBS로 세척하고 10% 포름알데히드로 1시간 이상 고정한 다음, 60% 이소프로판올로 세포를 3~4회 세척하였다. 각 웰에 Oil red O 용액을 넣고 10분 동안 염색한 다음 증류수로 세척하였다. 이후 100% 이소프로판올로 Oil red O 염료를 녹여 지방을 추출한 다음 520㎚의 흡광도에서 지방구 축적률을 평가하였다.Thereafter, the cells were washed with PBS and fixed with 10% formaldehyde for 1 hour or more, and then the cells were washed 3 to 4 times with 60% isopropanol. Oil red O solution was added to each well, stained for 10 minutes, and washed with distilled water. Thereafter, fat was extracted by dissolving Oil red O dye in 100% isopropanol, and then the fat glomerular accumulation rate was evaluated at absorbance at 520 nm.
조건condition | 지방구 축적률(%)Fat accumulation rate (%) |
대조군(무처리군)Control group (untreated group) | 100100 |
실시예 1Example 1 | 6565 |
실시예 2Example 2 | 6060 |
실시예 3Example 3 | 6161 |
실시예 4Example 4 | 6666 |
실시예 5Example 5 | 6565 |
실시예 6Example 6 | 6464 |
실시예 7Example 7 | 6565 |
비교예 1Comparative Example 1 | 6262 |
비교예 2Comparative Example 2 | 9797 |
비교예 3Comparative Example 3 | 8282 |
비교예 4Comparative Example 4 | 8080 |
비교예 8Comparative Example 8 | 8585 |
표 3을 살펴보면, 본 발명 실시예의 효소 식품 조성물(200㎍/㎖ 처리)은 지방구 축적 억제에 대한 상승효과를 나타내었다. 특히 본 발명자들은 다양한 혼합비로 효소 식품 조성물을 제조하고 지방구 축적률을 확인하였으며, 그 결과 상기 실시예와는 다른 혼합비로 제조한 조성물의 경우 혼합에 의한 상승효과가 낮았음을 확인하였다. 또한 쥐눈이콩 청국장 분말인 실시예 1 내지 7은 일반 메주콩을 사용한 청국장 분말인 비교예 8에 비해 항비만 효과가 우수함을 확인할 수 있었다.Looking at Table 3, the enzyme food composition (200㎍ / ㎖ treatment) of the embodiment of the present invention showed a synergistic effect on the inhibition of lipid accumulation. In particular, the present inventors prepared an enzyme food composition at various mixing ratios and confirmed the fat globules accumulation rate, and as a result, it was confirmed that the composition prepared at a mixing ratio different from the above example had a low synergistic effect by mixing. In addition, it was confirmed that Examples 1 to 7, which is a cheonggukjang powder of rat eyes, have superior anti-obesity effect compared to Comparative Example 8, which is a cheonggukjang powder using ordinary soybeans.
이로부터, 비만 개선시 본 발명과 같이 특정 혼합비로 혼합하여 사용하는 것이 항비만 효과를 나타내는데 가장 효과적임을 알 수 있었다.From this, it can be seen that when improving obesity, mixing it at a specific mixing ratio as in the present invention is the most effective in exhibiting the anti-obesity effect.
<실험예 2. 주름 개선 효과 확인><Experimental Example 2. Wrinkle improvement effect confirmation>
주름 개선 효과를 확인하고자 MMP-1의 발현량 변화를 확인하였다. To confirm the wrinkle improvement effect, a change in the expression level of MMP-1 was confirmed.
먼저 HaCaT 세포(인간각질형성세포)의 배양을 위해 DMEM 배지에 10% FBS와 1% 페니실린/스트렙토마이신을 첨가하여 37℃ 및 5% CO2 조건에서 계대배양하였다.First, 10% FBS and 1% penicillin/streptomycin were added to DMEM medium for culturing HaCaT cells (human keratinocytes), and subcultured at 37° C. and 5% CO 2 conditions.
플레이트에 계대 배양한 HaCaT 세포를 분주하고 본 발명 실시예 또는 비교예의 효소 식품 조성물을 DMSO에 녹여 200㎍/㎖로 처리하여 24시간 동안 배양하였다. 이후, UV-B(30mJ/㎠)를 조사하여 24시간 동안 배양한 다음, 세포로부터 MMP-1의 mRNA 발현량을 확인하고, 결과를 표 4에 나타내었다.The subcultured HaCaT cells were dispensed on the plate, and the enzyme food composition of Examples or Comparative Examples of the present invention was dissolved in DMSO, treated with 200 μg/ml, and cultured for 24 hours. Thereafter, the cells were irradiated with UV-B (30 mJ/cm 2 ) and cultured for 24 hours, and then the mRNA expression level of MMP-1 was confirmed from the cells, and the results are shown in Table 4.
조건condition | mRNA 발현량(%)mRNA expression level (%) |
대조군(무처리군)Control group (untreated group) | 100100 |
실시예 1Example 1 | 4545 |
실시예 2Example 2 | 4848 |
실시예 3Example 3 | 4848 |
실시예 4Example 4 | 5050 |
실시예 5Example 5 | 5353 |
실시예 6Example 6 | 5555 |
실시예 7Example 7 | 5151 |
비교예 1Comparative Example 1 | 9999 |
비교예 2Comparative Example 2 | 4040 |
비교예 5Comparative Example 5 | 8383 |
표 4를 참고하면, 자외선에 의해 노화가 유도된 HaCaT 세포에서, 본 발명의 효소 식품 조성물을 처리하는 경우 콜라겐 분해 효소인 MMP-1의 mRNA 발현량 감소 효과가 우수하였다.이러한 결과로부터 본 발명의 효소 식품 조성물은 항비만 효과 및 피부 주름 개선 효과가 우수하여, 체중 감량시 나타날 수 있는 피부 주름을 방지하면서도 항비만 효과는 우수한 비만 및 피부 주름 개선용 효소 식품 조성물로 용이하게 사용 가능한 조성물임을 알 수 있었다.Referring to Table 4, in HaCaT cells induced by UV rays, when the enzyme food composition of the present invention was treated, the effect of reducing the mRNA expression level of MMP-1, a collagen degrading enzyme, was excellent. The enzyme food composition has excellent anti-obesity effect and skin wrinkle improvement effect, so it can be seen that it is a composition that can be easily used as an enzyme food composition for improving obesity and skin wrinkle with excellent anti-obesity effect while preventing skin wrinkles that may appear during weight loss. there was.
<실험예 3. 관능검사><Experimental Example 3. Sensory Test>
본 발명의 실시예 및 비교예의 효소 식품 조성물에 대한 관능검사를 실시하기 위해, 훈련된 패널요원 20명이 7점 척도법을 사용하여 각각의 식품에 대해 관능검사를 실시하였다. In order to conduct a sensory test on the enzyme food compositions of Examples and Comparative Examples of the present invention, 20 trained panelists performed a sensory test for each food using a 7-point scale method.
먼저 실시예 및 비교예의 조건으로 제조된 효소 식품 조성물 10g을 물 100㎖에 녹여 효소 식품 조성물의 맛과 향에 대해 기호도를 확인하였다. 청국장 또는 장어 점액질의 불쾌한 맛 또는 향에 대한 저감 효과가 높으면 높은 수치(7점)로 평가하였고 저감 효과가 없으면 낮은 수치(0점)로 평가(저감 효과 매우 높음(7점), 저감 효과 높음(5점), 저감 효과 보통(3점), 저감 효과 낮음(1점), 저감 효과 없음(0점))하여 하기 표 5에 나타내었다. 하기 표 5에는 20명이 평가한 점수의 평균으로 소수점 1자리까지만 나타내었다. First, 10 g of the enzyme food composition prepared under the conditions of Examples and Comparative Examples was dissolved in 100 ml of water to confirm the taste and flavor of the enzyme food composition. If the reduction effect on the unpleasant taste or smell of cheonggukjang or eel slime was high, it was evaluated as a high value (7 points), and if there was no reduction effect, it was evaluated as a low value (0 points) (the reduction effect is very high (7 points), the reduction effect is high ( 5), moderate reduction effect (3 points), low reduction effect (1 point), no reduction effect (0 points)) are shown in Table 5 below. In Table 5 below, the average of the scores evaluated by 20 people is shown only to one decimal place.
조건condition | 맛에 대한 기호도taste preference | 향에 대한 기호도preference for incense |
실시예 1Example 1 | 6.86.8 | 6.96.9 |
실시예 2Example 2 | 6.96.9 | 6.96.9 |
실시예 3Example 3 | 6.76.7 | 6.66.6 |
실시예 4Example 4 | 6.96.9 | 6.96.9 |
실시예 5Example 5 | 6.96.9 | 6.96.9 |
실시예 6Example 6 | 6.96.9 | 6.96.9 |
실시예 7Example 7 | 6.86.8 | 6.86.8 |
비교예 1Comparative Example 1 | 1.11.1 | 1.01.0 |
비교예 2Comparative Example 2 | 0.70.7 | 1.01.0 |
비교예 3Comparative Example 3 | 1.51.5 | 1.31.3 |
비교예 5Comparative Example 5 | 1.11.1 | 1.11.1 |
상기 표 5의 결과로부터 본 발명의 효소 식품 조성물은 섭취시 불쾌한 맛과 향이 제거되어 섭취가 용이한 것임을 알 수 있었다. 따라서, 본 발명과 같이 쥐눈이콩 청국장 분말 및 장어 점액질 분말을 특정 비율로 혼합한 혼합물은 체중 감량시 나타날 수 있는 피부 주름을 방지하면서도 항비만 효과는 우수하고 섭취시 불쾌한 맛과 향이 제거되어 섭취가 용이하며 폐기되는 장어 점액질을 활용할 수 있어, 비만 및 피부 주름 개선용 효소 식품 조성물로 용이하게 사용 가능한 조성물임을 알 수 있었다.From the results of Table 5, it was found that the enzyme food composition of the present invention is easy to consume because unpleasant taste and flavor are removed when ingested. Therefore, as in the present invention, a mixture of cheonggukjang powder and eel mucilage powder in a specific ratio as in the present invention prevents skin wrinkles that may appear during weight loss, has an excellent anti-obesity effect, and is easy to consume because unpleasant taste and flavor are removed when ingested It was found that the composition can be easily used as an enzyme food composition for improving obesity and skin wrinkles by utilizing the discarded eel mucilage.
Claims (4)
- 쥐눈이콩 청국장, 장어 점액질 및 감미료를 포함하는 비만 및 피부 주름 개선용 효소 식품 조성물.Enzyme food composition for improving obesity and skin wrinkles, comprising cheonggukjang, eel mucilage and sweetener.
- 제1항에 있어서,According to claim 1,상기 쥐눈이콩 청국장, 장어 점액질 및 감미료는 6.5~8:1~2:0.1~1.5의 혼합비로 혼합된 것을 특징으로 하는 비만 및 피부 주름 개선용 효소 식품 조성물.The enzymatic food composition for improving obesity and skin wrinkles, characterized in that the rat eye bean cheongkukjang, eel mucilage and sweetener are mixed in a mixing ratio of 6.5-8:1-2:0.1-1.5.
- 제1항에 있어서,According to claim 1,상기 감미료는 스테비아, 꿀, 아스파탐, 에리스리톨, 자일리톨, 대추야자, 메이플시럽, 아가베시럽, 수카나트 및 천연 과일 분말로 이루어진 군에서 선택되는 1종 이상의 저칼로리 감미료인 것을 특징으로 하는 비만 및 피부 주름 개선용 효소 식품 조성물.The sweetener is at least one low-calorie sweetener selected from the group consisting of stevia, honey, aspartame, erythritol, xylitol, date palm, maple syrup, agave syrup, sucanat and natural fruit powder. Enzyme food composition for use.
- 제1항에 있어서,According to claim 1,상기 쥐눈이콩 청국장 및 장어 점액질은 동결건조한 분말인 것을 특징으로 하는 비만 및 피부 주름 개선용 효소 식품 조성물.The enzyme food composition for improving obesity and skin wrinkles, characterized in that the rat eye bean cheonggukjang and eel mucilage is a freeze-dried powder.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200019124A KR102453180B1 (en) | 2020-02-17 | 2020-02-17 | Composition of enzyme food for improving obesity and skin wrinkle comprising Rhynchosia Nulubilis cheonggukjang and mucus from eel |
KR10-2020-0019124 | 2020-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2021167311A2 true WO2021167311A2 (en) | 2021-08-26 |
WO2021167311A3 WO2021167311A3 (en) | 2021-10-14 |
Family
ID=77391042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2021/001940 WO2021167311A2 (en) | 2020-02-17 | 2021-02-16 | Enzyme food composition for ameliorating obesity and skin wrinkles, comprising fast-fermented rhynchosia nulubilis paste and eel mucus |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102453180B1 (en) |
WO (1) | WO2021167311A2 (en) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020000337A (en) | 2000-06-23 | 2002-01-05 | 이주영 | System and method of photo on-line service on internet |
KR20090105202A (en) | 2008-04-01 | 2009-10-07 | 주식회사 두향원 | Fermented soybeans for body fat control and the method of thereof |
KR101122393B1 (en) * | 2009-02-06 | 2012-03-23 | 정윤자 | A process for preparing fermented soybean pills contained oriental medicines and fermented soybean pills prepared thereby |
KR101003463B1 (en) * | 2009-03-24 | 2010-12-28 | 정윤자 | A process forpreparing fermented soybean pills efficacious against atopic dermatitis |
KR20120057013A (en) * | 2010-11-26 | 2012-06-05 | 최형찬 | Preparation Method Of Health Food Using Rhynchosia Nulubilis And Onion |
KR101460669B1 (en) | 2012-11-23 | 2014-11-11 | 주식회사 뉴메디온 | Cosmetic composition with mucus from fish |
KR101676318B1 (en) * | 2015-04-29 | 2016-11-29 | 주식회사 리온메디코스 | A system of gathering excreta from eel skin with extract mucin from excreta |
KR101697152B1 (en) * | 2016-07-12 | 2017-01-17 | 주식회사 리온메디코스 | Manufacturing method of cosmetic material having an anti-aging effect using mucin from eel skin |
CN106727243A (en) * | 2016-12-29 | 2017-05-31 | 邓运春 | A kind of skin care item formula containing yellow eel pituitary extract and preparation method thereof |
KR20190027236A (en) | 2017-09-06 | 2019-03-14 | (주)할머니청국장 | Fermented Rhynchosia nulubilis extract having superior for Anti-obesity effect and manufacturing method thereof |
KR102002337B1 (en) * | 2019-02-12 | 2019-07-22 | 유시호 | A manufacturing method of Cheong Kuk Jang having red ginseng paste |
-
2020
- 2020-02-17 KR KR1020200019124A patent/KR102453180B1/en active IP Right Grant
-
2021
- 2021-02-16 WO PCT/KR2021/001940 patent/WO2021167311A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR20210104417A (en) | 2021-08-25 |
WO2021167311A3 (en) | 2021-10-14 |
KR102453180B1 (en) | 2022-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4470212B2 (en) | Skin improver | |
KR101615199B1 (en) | Functional compositions for relieving hangovers and protecting a liver, healthy food and food additive comprising the same | |
JP2006045212A (en) | Oral composition containing specific quinic acid derivative | |
KR101439321B1 (en) | Functional pear fermented liquid using by-product of pear processing and its application method | |
WO2019124862A1 (en) | Skin wrinkle prevention and improvement composition containing schisandra chinensis extract as active ingredient | |
KR20190123921A (en) | A method for preparing functional pills comprising extracts of natural materials | |
KR101904702B1 (en) | Composition for immune enhancement and method the same | |
KR102126458B1 (en) | Method for Manufacturing Fermented Sea Cucumber Tea | |
KR20160092631A (en) | The manufacturing method of aronia powder food and the product | |
KR20170106187A (en) | Antioxidant Composition | |
KR20200079215A (en) | Composition for Silkworm-collagen and manufacturing method thereof | |
KR102453180B1 (en) | Composition of enzyme food for improving obesity and skin wrinkle comprising Rhynchosia Nulubilis cheonggukjang and mucus from eel | |
JP2003339353A (en) | Food for beauty | |
KR20090103823A (en) | Anti-aging agent external preparation for skin, and food and drink | |
KR20230080923A (en) | Method for producing a ferment extract of the centella asiatica and composition for antiocidative comprising the ferment extract of the centella asiatica produced by the same | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
KR20080100942A (en) | Compositions for improving liver function | |
CN104738700B (en) | A kind of loach protect liver product and preparation method thereof | |
KR102249711B1 (en) | Composition for enhancing skin elasticity or improving skin wrinkels comprising enzyme treated extract of leguminous plants cultured root | |
WO2019235866A1 (en) | Method for preparing fermented pineapple having increased antioxidant effect by using vitamin c | |
CN112042846A (en) | Sea-buckthorn solid beverage for enhancing immunity and inhibiting tumors and preparation method thereof | |
KR102167812B1 (en) | Fermented product of sorghum-adzuki bean mixture for intestinal health and improvement effect of bowel | |
KR20210086438A (en) | Bacillus subtilis strain jnucc having anti-alpha glucosidase and anti-tyrosinase activity effect and use thereof | |
KR101147922B1 (en) | Cosmetic composition and skin beauty food | |
KR20200084560A (en) | Anti-inflammatory composition comprising extract of Scapharca broughtonii hydrolysate as effective component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21757947 Country of ref document: EP Kind code of ref document: A2 |